Skip to content
Open access

NeuroAid An Open-Data Multimodal Screening Framework for Parkinson's and Depression Risk Estimation

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

NeuroAid, an open-data multimodal AI screening framework that estimates condition-specific risk from non-invasive, accessible signals spanning acoustic speech biomarkers, facial and video-based affective cues, and clinical or behavioral digital biomarkers, is presented.

Abstract

Neurological and mental-health conditions such as Parkinson's disease (PD) and major depressive disorder (MDD) impose a substantial and growing global burden, yet reliable early screening remains largely confined to specialist clinical settings that are inaccessible to the majority of affected individuals. We present NeuroAid, an open-data multimodal AI screening framework that estimates condition-specific risk from non-invasive, accessible signals spanning acoustic speech biomarkers, facial and video-based affective cues, and clinical or behavioral digital biomarkers. NeuroAid is organized as a modular, branch-wise pipeline covering three independent signal pathways: audio, vision, and behavioral, unified by a frozen-embedding late-fusion layer that produces interpretable joint risk scores. A participant-safe, subject-grouped splitting protocol is enforced throughout, preventing inter-subject data leakage, a frequently overlooked cause of artificially inflated performance in clinical machine learning benchmarks. On the Figshare Parkinson's audio dataset, a proposed small-data protocol combining frozen WavLM foundation-model embeddings with a grouped SVM-RBF classifier achieves a cross-validated balanced accuracy of 0.786 +/- 0.073 and a held-out test balanced accuracy of 75.0%, an F1-score of 80.0%, and an AUC-ROC of 82.8%. The depression vision branch, trained on the DepVidMood corpus via transfer learning from FER-2013, reaches a threshold-tuned test balanced accuracy of 59.7% and is presented as an honest hard-case baseline under severe class imbalance. NeuroAid is further distinguished by its production-grade MLOps scaffolding, including orchestrated branch training, JSON and Markdown artifact reporting, a deployable Streamlit screening interface, and a complete CI/CD workflow. The entire system is built exclusively on publicly available datasets, ensuring full reproducibility. All code, artifacts, and benchmark outputs are versioned and deployable via Docker.

Read PDF

Similar papers

Conference

Enhancing Early Dementia Detection with AI and Character-Level Speech Biomarkers

The rising prevalence of neurocognitive disorders, such as Alzheimer’s disease (AD), poses a significant global health challenge. Traditional diagnostic methods, including clinical interviews and paper-based tests like the Mini-Mental State Examination (MMSE), Mini-Cog Test, and Montreal Cognitive Assessment (MoCA), ar...

K. Mekulu, Hui Yang, Faisal Aqlan · 0 citations
Open access Sep 2026

Non-Invasive Parkinson's Disease Screening from Vocal Biomarkers: A Subject-Level Machine Learning Framework with Bayesian Optimisation and Explainable AI

An estimated ten million people live with Parkinson's, yet timely diagnosis remains constrained by specialist assessment, costly imaging, and unequal care access. Phonation analysis offers a low-cost alternative: dopaminergic degeneration causes vocal impairments years before motor symptoms emerge, enabling community s...

Ryan Wyton, Raza Hasan · 0 citations
Open access Aug 2026

Large Language and Ensemble Powered Enhanced Parkinson's Detection Model

A novel ensemble-driven machine learning framework that leverages acoustic features from speech signals for early PD detection and incorporates a post-diagnostic chatbot powered by a Large Language Model (LLM), enabling personalised support and guidance.

Seema Gaba, Harpreet Kaur, Arun Singh · 0 citations
Open access Aug 2026

Comparative Analysis of Deep Learning Models on Depression Prediction

Major depressive disorder (MDD) is a severe psychiatric condition characterized by persistent emotional, cognitive, and functional impairments. Traditional diagnostic approaches heavily rely on subjective self-report scales and clinical observations, which are inherently vulnerable to recall biases and social desirabil...

Jia-Min Li · 0 citations
Open access 2026

A Multi-Input Neural Network for Early Detection of Neurological Disordersfrom Vocal and Sleep Data

A multi-input deep neural network that integrates vocal biomarkers and clinical sleep-related features to improve diagnostic accuracy and demonstrates consistent improvements over early and late fusion strategies, demonstrating the benefit of modality-specific representation learning.

Md Shujan Shak, Nabila Rahman, Fuad Mahmud et al. · 0 citations
Oct 2026

AlzDetect: A Heterogeneous Framework for Early Alzheimer Detection Using Unified Multimodal Indicators

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder for which early risk identification is essential for timely clinical assessment, care planning, and long-term disease management. However, computational modeling of AD remains challenging because clinically meaningful diagnosis cannot be inferred from...

Aarju Dixit, Debasis Das · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.